Clodronate liposome treatment contributes to the nerve regeneration in corneal nerve involvement of diabetic mice.

clodronate cornea diabetes nerve regeneration neurotrophic keratopathy

Journal

Experimental animals
ISSN: 1881-7122
Titre abrégé: Exp Anim
Pays: Japan
ID NLM: 9604830

Informations de publication

Date de publication:
06 Aug 2024
Historique:
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 7 8 2024
Statut: aheadofprint

Résumé

The dense nerve and thin vascular structure of the corneal tissue provide the refractive function in healthy eyes. Diabetes mellitus causes ocular complications including corneal opacification because of corneal nerve degeneration. Diabetic neurotrophic keratopathy is characterized by reduced corneal sensitivity, delayed corneal wound healing, and nerve degeneration. Neurotization and vascularization inhibit each other in the cornea. Macrophages contribute to the corneal neovascularization. To investigate the role of macrophage in neurotrophic keratopathy, clodronate liposome was subconjunctivally injected into diabetic db/db mice with neurotrophic keratopathy. The clodronate liposome treatment decreased F4/80

Identifiants

pubmed: 39111878
doi: 10.1538/expanim.24-0063
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Hiroki Ueno (H)

Department of Immunology and Parasitology, St. Marianna University School of Medicine.

Takaaki Hattori (T)

Department of Ophthalmology, Tokyo Medical University.

Hsi-Hua Chi (HH)

Department of Animal Models for Human Diseases, Institute of Biomedical Science, Kansai Medical University.

Yoshishige Miyabe (Y)

Department of Immunology and Parasitology, St. Marianna University School of Medicine.

Masanori A Murayama (MA)

Department of Animal Models for Human Diseases, Institute of Biomedical Science, Kansai Medical University.

Classifications MeSH